Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.


NDAQ:APDN - Post by User

Post by turner20001on Sep 26, 2023 1:44pm
50 Views
Post# 35655043

Applied DNA Sciences, Inc. Loses Appeals on Former Employees

Applied DNA Sciences, Inc. Loses Appeals on Former Employees

The California Unemployment Appeals Board has ruled against Applied DNA Sciences, Inc. (OTCBB:APDN) in its effort to disqualify three former employees from receiving unemployment insurance benefits under section 256 of the California Unemployment Insurance Code. APDN, presently based in Stony Brook, New York, claims to offer botanical DNA-based protection against counterfeiting, fraud, identity theft and similar illegal acts.

“Two of the three former executives worked for several months without pay, out of loyalty to the company and promises based on supposedly groundbreaking technology provided by Biowell Technologies Inc. of Taiwan, and the third remained in employment limbo. After terminating the employees without explanation, APDN claimed that the employees were separated from their jobs because of fraudulent activity,” says Peter M. Kunstler, attorney for the claimants. “The Appeals Board agreed that fraud and collusion are false charges. We believe the terminations actually resulted from an array of breaches by both old and new management.”

Kunstler, of the law firm Makarem & Associates APLC, is preparing for the May, 2007 trial of a civil suit against APDN on behalf of four former employees, based on breach of contract and violations of California Labor Law.

APDN hired the claimants in 2003 and 2004. Concerns over their employment status and changes in the direction of the company led the claimants to request written severance agreements. The COO/Acting CFO/Contracts Manager of the company, Karin Klemm, executed Addenda to the claimants’ employment contracts, which new management contended were fraudulently procured. This was the basis for APDN’s challenge which the ALJ overruled in the decision confirmed by the Appeals Board.

<< Previous
Bullboard Posts
Next >>